MTMVI puts the spotlight on Diabetic Retinal Disease
From June 23-26, scientists and healthcare professionals will gather in San Diego for the American Diabetes Association’s (ADA) 83rd Scientific Sessions, one of the largest conferences of diabetes researchers in the world.
Staff and scientists from the Mary Tyler Moore Vision Initiative (MTMVI) will also be there to present the initiative’s goals and approach to ending Diabetic Retinal Disease (DRD). This session which is themed around Acute and Chronic Complications of diabetes, will be held on Sunday, June 25th. Join us in room 25 for Session AC-1.5-SY15 if you’re in attendance!
Here’s the session agenda:
Creating a World without Visual Loss from Diabetes
Sunday, June 25, 2023
4:30 p.m.-4:45 p.m. The Goal of Eliminating Blindness from Diabetic Retinal Disease
S. Robert Levine, MD
4:45 p.m.-5:00 p.m. The Importance of Studying the Human Retinal Disease
Patrice E. Fort, MS, PhD
5:00 p.m.-5:15 p.m. Structure-Function Connections in Human Diabetic Retinal Disease
Stela Vujosevic, MD, PhD
5:15 p.m.-5:30 p.m. Designing Clinical Trials Based on Advanced Understanding of Diabetic Retinal Disease
Jennifer Sun, MO, MPH
5:30 p.m.-6:00 p.m. Question and Discussion Period
Image of San Diego Convention Center courtesy of Port of San Diego
